HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE

Catalog No:
MBL-TS-M012-1
$1,470.00

Formerly Catalog No.: TB-M012-1

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence pp65
Class Class I
Sequence Location 501-509
MHC Allele A*11:01

Documents & Links

Documents & Links for HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE
Datasheet HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE Datasheet

Documents & Links for HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE
Datasheet HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence pp65
Class Class I
Sequence Location 501-509
MHC Allele A*11:01

Documents & Links

Documents & Links for HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE
Datasheet HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE Datasheet

Documents & Links for HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE
Datasheet HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE Datasheet